Role of intramural platelet thrombus in the pathogenesis of wall rupture and intra-ventricular thrombosis following acute myocardial infarction

Thrombosis and Haemostasis

Volumn 105, Issue 2, 2011, Pages 356-364

  Du, Xiao Jun ^a   Shan, Leonard ^a   Gao, Xiao Ming ^a   Kiriazis, Helen ^a   Liu, Yang ^a   Lobo, Abhirup ^a   Head, Geoffrey A ^a   Dart, Anthony M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Anti platelet drugs; Haemodynamics; Inflammation; Intramural thrombus; Left ventricular thrombus; Myocardial infarction; Platelet; Ventricular rupture

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PRASUGREL;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD CLOT; CONTROLLED STUDY; DRUG EFFECT; HEART RUPTURE; HEART VENTRICLE THROMBOSIS; HISTOPATHOLOGY; INFLAMMATORY CELL; INTRAMURAL PLATELET THROMBUS; LOADING DRUG DOSE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTE; THROMBOGENESIS; THROMBUS;

ANIMALS; ASPIRIN; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; HEMODYNAMICS; INFLAMMATION; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; TELEMETRY; THROMBOSIS; TICLOPIDINE; TIME FACTORS; VENTRICULAR SEPTAL RUPTURE;

EID: 79851493082     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-07-0449     Document Type: Article

References (40)

1. Becker RC, Gore JM, Lambrew C, et al. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol 1996; 27: 1321-1326. (Pubitemid 26151666)
2. Figueras J, Alcalde O, Barrabes JA, et al. Changes in hospital mortality rates in 425 patients with acute ST-elevation myocardial infarction and cardiac rupture over a 30-year period. Circulation 2008; 118: 2783-2789.
3. Porter A, Kandalker H, Iakobishvili Z, et al. Left ventricular mural thrombus after anterior ST-segment-elevation acute myocardial infarction in the era of aggressive reperfusion therapy- still a frequent complication. Cor Artery Dis 2005; 16: 275-279. (Pubitemid 41073295)
4. van Dantzig JM, Delemarre BJ, Bot H, et al. Left ventricular thrombus in acute myocardial infarction. Eur Heart J 1996; 17: 1640-1645. (Pubitemid 26381821)
5. Domenicucci S, Chiarella F, Bellotti P, et al. Early appearance of left ventricular thrombi after anterior myocardial infarction: a marker of higher in-hospital mortality in patients not treated with antithrombotic drugs. Eur Heart J 1990; 11: 51-58. (Pubitemid 20042307)
6. Osherov AB, Borovik-Raz M, Aronson D, et al. Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era. Am Heart J 2009; 157: 1074-1080.
7. Rabbani L, Waksmonski C, Iqbal S, et al. Determinants of left ventricular thrombus formation after primary percutaneous coronary intervention for anterior wall myocardial infarction. J Thromb Thrombol 2008; 25: 141-145. (Pubitemid 351583662)
8. Küpper AJ, Verheugt FW, Peels CH, et al. Left ventricular thrombus incidence and behavior studied by serial two-dimensional echocardiography in acute anterior myocardial infarction: left ventricular wall motion, systemic embolism and oral anticoagulation. J Am Coll Cardiol 1989; 13: 1514-1520. (Pubitemid 19145549)
9. Hutchins KD, Skurnick J, Lavenhar M, et al. Cardiac rupture in acute myocardial infarction: a reassessment. Am J Forensic Med Pathol 2002; 23: 78-82. (Pubitemid 34225806)
10. Spirito P, Bellotti P, Chiarella F, et al. Prognostic significance and natural history of left ventricular thrombi in patients with acute anterior myocardial infarction: a two-dimensional echocardiographic study. Circulation. 1985; 72: 774-780. (Pubitemid 16245187)
11. Fang L, Gao XM, Moore XL, et al. Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol 2007; 43: 535-544. (Pubitemid 47615041)
12. Gao XM, Xu Q, Kiriazis H, et al. Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. Cardiovasc Res 2005; 65: 469-477. (Pubitemid 40082489)
13. Heymans S, Luttun A, Nuyens D, et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999; 5: 1135-1142. (Pubitemid 29474417)
14. Matsumura S, Iwanaga S, Mochizuki S, et al. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest. 2005; 115: 599-609. (Pubitemid 40322234)
15. Kameda K, Matsunaga T, Abe N, et al. Increased pericardial fluid level of matrix metalloproteinase-9 activity in patients with acute myocardial infarction: possible role in the development of cardiac rupture. Circ J 2006; 70: 673-678. (Pubitemid 43797776)
16. van den Borne SWM, Cleutjens JPM, Hanemaaijer R, et al. Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. Cardiovascr Pathol 2008; 18: 37-43.
17. Zidar N, Jeruc J, Balazic J, et al. Neutrophils in human myocardial infarction with rupture of the free wall. Cardiovasc Pathol 2005; 14: 247-250. (Pubitemid 41317271)
18. Gao XM, Ming Z, Su Y, et al. Infarct size and post-infarct inflammation determine the risk of cardiac rupture in mice. Int J Cardiol 2010; 143: 20-28.
19. Head GA, Obeyesekere VR, Jones ME, et al. Aromatase-deficient (ArKO) mice have reduced blood pressure and baroreflex sensitivity. Endocrinology 2004; 145: 4286-4291. (Pubitemid 39120578)
20. Mangin P, Yap CL, Nonne C, et al. Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcR? deficiency. Blood. 2006; 107: 4346-4353. (Pubitemid 43801360)
21. Evangelista V, Manarini S, Dell'Elba G, et al. Clopidogrel inhibits platelet-leukocyte adhesion and plateletdependent leukocyte activation. Thromb Haemost 2005; 94: 568-577. (Pubitemid 41300854)
22. Hashimoto M, Sugidachi A, Isobe T, et al. The influence of P2Y12 receptor deficiency on the platelet inhibitory activities of prasugrel in a mouse model: evidence for specific inhibition of P2Y12 receptors by prasugrel. Biochem Pharmacol 2007; 74: 1003-1009. (Pubitemid 47284007)
23. Teng CM, Wu CC, Ko FN, et al. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice. Eur J Pharmacol 1997; 320: 161-166.
24. Majno G, Joris I. Hemostasis and thrombosis. In: Cells, Tissues, and Disease. Principles of General Pathology. Blackwell Science, Cambridge, USA. 1996: pp. 609-644.
25. Lopez-Sendon J, Gonzalez A, Lopez de Sa E, et al. Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria. J Am Coll Cardiol 1992; 19: 1145-1153.
26. Oliva PB, Hammill SC, Edwards WD. Cardiac rupture, a clinically predictable complication of acute myocardial infarction: report of 70 cases with clinicopathologic correlations. J Am Coll Cardiol 1994; 22: 1518-1519.
27. Davies MJ. Thrombosis in acute myocardial infarction and sudden death. Cardiovasc Clin 1987; 18: 151-159. (Pubitemid 17109572)
28. Maseri A, Chierchia S, Davies G. Pathophysiology of coronary occlusion in acute infarction. Circulation 1986; 73: 233-239. (Pubitemid 16127398)
29. Sharpe N. Ventricular remodeling following myocardial infarction. Am J Cardiol 1992; 70: 20C-26C.
30. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359: 938-949.
31. von Hundelshausen P, Weber C. Platelets as immune cells: Bridging inflammation and cardiovascular disease. Circ Res 2007; 100: 27-40. (Pubitemid 46066771)
32. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil- interactions: linking hemostasis and inflammation. Blood Rev 2007; 21: 99-111. (Pubitemid 46428465)
33. Muhlestein JB. Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients. Thromb Haemost 2010; 103: 71-82.
34. Mark AL. The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol 1983: 90-102. (Pubitemid 13193279)
35. Takada A, Saito K, Murai T, Ro A, Hamamatsu A. Pathological evaluation of coronary lesions in cases of cardiac rupture during acute myocardial infarction: an autopsy study of 148 out-of-hospital sudden death cases. Pathol Res Pract 2009; 205: 241-247.
36. da Trindade M, Tsutsui J, Rodrigues A, et al. Left ventricular free wall impeding rupture in post-myocardial infarction period diagnosed by myocardial contrast echocardiography: Case report. Cardiovasc Ultrasound 2006; 4: 7.
37. Mann JM, Roberts WC. Rupture of the left ventricular free wall during acute myocardial infarction: analysis of 138 necropsy patients and comparison with 50 necropsy patients with acute myocardial infarction without rupture. Am J Cardiol 1988; 62: 847-859.
38. Ganame J, Messalli G, Dymarkowski S, et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J 2009; 152: 75-84.
39. López-Sendón J, Gurfinkel EP, Lopez de Sa E, et al. Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events. Eur Heart J 2010; 31: 1449-1456.
40. Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366: 1607-1621.